CD14 and COVID-19: Consistent with hepcidin-mediated iron redistribution, we observed transcriptional signatures of iron accumulation in circulating CD16+ classical and CD14+ nonclassical monocytes, potentially predisposing them to cellular dysfunction through ROS-mediated damage and contributing to tissue and organ pathology in patients with COVID-19.